These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 7483789)
1. Rapid vaccination protocols for commercial vaccines against tick-borne encephalitis. Stephenson JR; Lee JM; Easterbrook LM; Timofeev AV; Elbert LB Vaccine; 1995; 13(8):743-6. PubMed ID: 7483789 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091 [TBL] [Abstract][Full Text] [Related]
3. Vaccination against tick-borne encephalitis--distant evaluation. Bobrowska E; Grzeszczuk A; Prokopowicz D Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis. Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679 [TBL] [Abstract][Full Text] [Related]
5. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine. Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394 [TBL] [Abstract][Full Text] [Related]
6. Passive immunization reduces immunity that results from simultaneous active immunization against tick-borne encephalitis virus in a mouse model. Kreil TR; Burger I; Attakpah E; Olas K; Eibl MM Vaccine; 1998; 16(9-10):955-9. PubMed ID: 9682343 [TBL] [Abstract][Full Text] [Related]
7. [The significance of humoral immunity in post-vaccination resistance of mice to tick-borne encephalitis]. Nikonova AN; Rozhkova LV; Sokolova ED Tr Inst Im Pastera; 1989; 65():84-90. PubMed ID: 2560848 [No Abstract] [Full Text] [Related]
8. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis]. Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071 [TBL] [Abstract][Full Text] [Related]
9. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771 [TBL] [Abstract][Full Text] [Related]
10. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen]. El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574 [TBL] [Abstract][Full Text] [Related]
11. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm]. Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069 [TBL] [Abstract][Full Text] [Related]
12. Magnitude and Functional Profile of the Human CD4 Varnaitė R; Blom K; Lampen MH; Vene S; Thunberg S; Lindquist L; Ljunggren HG; Rombo L; Askling HH; Gredmark-Russ S J Immunol; 2020 Feb; 204(4):914-922. PubMed ID: 31924650 [TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge. Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605 [TBL] [Abstract][Full Text] [Related]
16. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents]. Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850 [TBL] [Abstract][Full Text] [Related]
17. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence. Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225 [TBL] [Abstract][Full Text] [Related]
18. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis]. Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575 [TBL] [Abstract][Full Text] [Related]
19. Field effectiveness of vaccination against tick-borne encephalitis. Heinz FX; Holzmann H; Essl A; Kundi M Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389 [TBL] [Abstract][Full Text] [Related]
20. [An assessment of the immunoepidemiological efficacy of a liquid cultured killed vaccine against tick-borne encephalitis virus strain 205 in the Maritime Territory]. Leonova GN; Liubimova NB; Sergeev GA; Muratkina SM; Krugliak SP; Bobkov AV; Bondarenko SI; Tutubalina GN; Beliaev MM Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):43-6. PubMed ID: 1441813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]